Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF OCTOBER 06, 2022 SAM #7615
SOURCES SOUGHT

A -- Request for Information: FDA Approved Anthrax Vaccines

Notice Date

10/4/2022 12:30:02 PM
 

Notice Type

Sources Sought
 

NAICS

541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
 

Contracting Office

W6QK ACC-APG ABERDEEN PROVING GROU MD 21010-5424 USA
 

ZIP Code

21010-5424
 

Solicitation Number

W911SR23SATXV
 

Response Due

10/18/2022 1:00:00 PM
 

Point of Contact

Susan E. Ruzicka, Phone: 3016198802
 

E-Mail Address

susan.e.ruzicka2.civ@army.mil
(susan.e.ruzicka2.civ@army.mil)
 

Description

Objective: This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this RFI. The Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical) and the Joint Program Executive Office for Chemical, biological, Radiological, and Nuclear Defense (JPEO-CBRND) is seeking information on the available capabilities and willingness of private entities (academic, non-profit, and commercial) to collaborate with the Government in the areas listed below. Background:� JPM CBRN Medical, is conducting market research seeking capabilities from more than one potential source for procurement of an anthrax vaccine. Anthrax Vaccine Adsorbed (AVA) will no longer be available to the Department of Defense (DoD) from the Administration for Strategic Preparedness and Response (ASPR) Strategic National Stockpile (SNS) beginning 2024.� Requirements: Candidate vaccine should have a minimum shelf life and storage of 4 years at 2-8oC (i.e., refrigerated) and have a Pre-Exposure Prophylaxis (PrEP) indication. Performance:�� The vaccine must be FDA approved, or able to obtain FDA approval within 6 months. �� Regulatory Objectives:� The vaccine shall meet or exceed the quality standards established by the current Good Manufacturing Practices (cGMP), Good Laboratory Practices (GLP), Good Clinical Practices (GCP) and FDA and/or International Conference on Harmonization (ICH) and International Organization for Standardization (ISO) Standards, for safety and efficacy of the product.� RFI: The Respondents shall provide the following in reply to the RFI, not to exceed 11 pages in total:� Company Description (2 page maximum). Provide a brief description of company history, alliances and funding emphasizing experience in vaccine development. FDA Approved Anthrax Vaccine Candidate Questions (9 page maximum) Detail your company�s FDA approved Anthrax vaccine. Provide your high-level Regulatory Strategy. What do you anticipate the cost per dose to be of your FDA approved Anthrax vaccine?�� What is the minimum production amount required for an Anthrax vaccine to keep your manufacturing line open? What is the maximum number (# of doses) of FDA approved Anthrax vaccine you can produce annually? Does your facility have cGMP storage capability of vaccine products? If so, what is your capacity to store vialed Anthrax vaccine? Administration: The Government will retain comments and information received in response to this RFI. Proprietary information should be identified as Company Proprietary. Do not use Government security classification markings. All written responses must be received by COB on 20 October 2022. Responses should be sent by e-mail to usarmy.detrick.mcs.mbx.baa@mail.mil, with Subject Line of Responding Organization and RFI Title. Material that is advertisement only in nature is not desired.� JPM Medical also manages a Broad Agency Announcement (BAA), which may be viewed on SAM.gov, keywords W911SR-22-R-CBRND at https://sam.gov/opp/66870bda25274773b3e5fa7cfd3c0e11/view. For questions related to this RFI, please email usarmy.detrick.mcs.mbx.baa@mail.mil. The Point of Contact for this RFI is Susan Ruzicka, at susan.e.ruzicka2.civ@army.mil.
 

Web Link

SAM.gov Permalink
(https://sam.gov/opp/a783250595ea4b2ea1c6e386226c029d/view)
 

Place of Performance

Address: Frederick, MD 21702, USA

Zip Code: 21702

Country: USA
 

Record

SN06486578-F 20221006/221004230124 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |